Stories similar to Global Pharmaceutical & Biotechnology Outlook 2013: Rising Stars:

Global Pharmaceutical & Biotechnology Outlook 2014: Rising Stars 48 weeks 6 days ago

Innovations have contributed to the availability of a range of new treatments for diseases resulting in improvement in the length and quality of life and reduced disease burden for individuals and society. However, the need for innovative therapies for unmet needs /challenging diseases continues to grow, accelerating the pace of drug development directly or through partnership/ in-licensing.

Global Pharmaceutical & Biotechnology Outlook 2 years 7 weeks ago

Bharat Book Bureau has announced the addition of the "Global Pharmaceutical & Biotechnology Outlook 2013: Global Pharma" report to their offering.

Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech 48 weeks 6 days ago

Positive sentiments for the biotech sector have prevailed in the last two to three years, and we expect this trend to continue for the next year too. Our optimism is based on the continuity in the flow of innovative products from their pipeline, implementation of strategic decisions to improve cost efficiency, strengthen therapeutic leadership, and hedge against generic threats – which all lend stability to the business model of the company. Focus and interest in Orphan diseases remains and Alexion kept everyone guessing on the possible acquisition.

Global Markets for Generic Drugs 23 weeks 5 days ago

The global generics sector reached $269.8 billion in 2012. This sector is expected to reach $300.9 billion in 2013 and $518.5 billion in 2018, with a compound annual growth rate (CAGR) of 11.5%.

This report provides:

-An overview of the global market for generic drugs, including coverage of therapeutics such as antibacterials, antidepressants, anticancer agents, anti-arthritics, cardiovascular drugs (e.g., hypolipidaemics and antihypertensives), and drugs for respiratory conditions, including asthma and COPD.

Infections Hepatitis Therapy Area Pipeline Report 5 years 14 weeks ago

Life Science Analytics'', Hepatitis Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of hepatitis drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.